Nutex Health (NUTX) to Release Earnings on Thursday

Nutex Health (NASDAQ:NUTX) is expected to be posting its Q2 2026 results after the market closes on Thursday, August 6th. Analysts expect Nutex Health to post earnings of $4.95 per share and revenue of $215.0310 million for the quarter. Investors can find conference call details on the company’s upcoming Q2 2026 earning report page for the latest details on the call scheduled for Friday, August 7, 2026 at 10:30 AM ET.

Nutex Health Stock Up 3.2%

Nutex Health stock opened at $157.80 on Wednesday. The stock has a market cap of $1.09 billion, a P/E ratio of 12.19 and a beta of 0.24. The company has a quick ratio of 3.12, a current ratio of 3.14 and a debt-to-equity ratio of 0.66. Nutex Health has a twelve month low of $77.21 and a twelve month high of $204.00. The company’s 50-day moving average price is $155.39 and its two-hundred day moving average price is $129.03.

Institutional Investors Weigh In On Nutex Health

Large investors have recently added to or reduced their stakes in the stock. Deutsche Bank AG raised its holdings in Nutex Health by 3.9% in the 4th quarter. Deutsche Bank AG now owns 2,633 shares of the company’s stock valued at $433,000 after acquiring an additional 98 shares in the last quarter. Russell Investments Group Ltd. increased its position in shares of Nutex Health by 1.4% in the fourth quarter. Russell Investments Group Ltd. now owns 8,706 shares of the company’s stock worth $1,433,000 after purchasing an additional 116 shares during the period. First Trust Advisors LP increased its position in shares of Nutex Health by 2.4% in the fourth quarter. First Trust Advisors LP now owns 11,461 shares of the company’s stock worth $1,887,000 after purchasing an additional 272 shares during the period. BNP Paribas Financial Markets raised its stake in Nutex Health by 966.7% in the second quarter. BNP Paribas Financial Markets now owns 320 shares of the company’s stock valued at $40,000 after purchasing an additional 290 shares in the last quarter. Finally, Royal Bank of Canada raised its stake in Nutex Health by 752.4% in the fourth quarter. Royal Bank of Canada now owns 358 shares of the company’s stock valued at $59,000 after purchasing an additional 316 shares in the last quarter. Institutional investors and hedge funds own 5.32% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have recently commented on NUTX shares. B. Riley Financial started coverage on Nutex Health in a research report on Friday, June 26th. They issued a “buy” rating and a $290.00 target price on the stock. Weiss Ratings raised Nutex Health from a “hold (c)” rating to a “hold (c+)” rating in a report on Tuesday, July 28th. Lake Street Capital initiated coverage on Nutex Health in a research note on Tuesday, June 2nd. They issued a “buy” rating and a $235.00 price target for the company. Zacks Research raised Nutex Health to a “hold” rating in a report on Monday, June 29th. Finally, Wall Street Zen cut Nutex Health from a “strong-buy” rating to a “buy” rating in a research report on Monday, July 20th. Three investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $243.33.

About Nutex Health

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.